Dongho Lee

Representation of The Carlyle Group on its US$200 million strategic investment and partnership between Carlyle Asia Partners V and KB Financial Group, Korea's largest bank.

Representation of Green Cross in relation to Artiva Biotherapeutics' $78 million Series A financing from 5AM Ventures, venBio Partners and RA Capital Management. Green Cross is the founder and controlling shareholder of Artiva.

Representation of a Korean infrastructure fund on various acquisitions and equity investments including its acquisition of a social infrastructure platform managing multiple university campuses in the Middle East 

Representation of a Korean private equity fund on various acquisitions and dispositions including its acquisition of a controlling interest in a fintech company in Vietnam and its sale of a controlling interest in a global IP management company to a competitor owned by a UK private equity fund

Representation of a Korean media and entertainment company and its investment arm on (1) their equity financings from a Chinse technology company and a European fashion company's investment arm and (2) various investments, including equity investments in a Singapore-based influencer marketing company, a Chinese user-generated-contents business and real estate development projects in Korea and the U.S.A.

Representation of a Korean sovereign wealth fund on various fund investments and co-investments in a wide range of target companies in Europe, Australia and the U.S.A.

Representation of the controlling shareholders of a Korean medical device company, on its equity financings and other corporate matters including the sale of a controlling stake in such company to a Japanese private equity fund 

Representation of a NASDAQ-listed Korean online/mobile game developer/publisher on its annual filings and other compliance matters

Representation of a Korea Exchange-listed online/mobile game developer/publisher on multiple equity investments in the U.S.A. and Europe

Representation of an international private equity fund on its acquisition of multiple waste management companies in Korea and the establishment of investment structure for such acquisition

Representation of a Korean conglomerate on its US$370 million strategic equity investment in a NASDAQ-listed vertically integrated PRC manufacturer of silicon ingots, wafers and photovoltaic cells and modules

Representation of a Korean technology company on the US$1.4 billion sale of its hard disk drive business to a NASDAQ-listed manufacturer of HDD and storage solutions, and extending and enhancing the existing patent cross-license agreement between the companies 

*Includes experience prior to joining White & Case.